Date Posted – 17 May 2021
The Minister for Health has announced that Snoretox has won a Medical Research Future Fund (MRFF) 2021 Frontier Health and Medical Research Initiative Grant, securing a 1 Million dollar 12 month grant and the important round 2 opportunity based on results to apply for a further $50 Million to fund Phase 2 and 3 trials of its FDA breakthrough status products.
The MRFF is a 20 Billion dollar fund set up by the Australian Federal Government to promote medical research and it’s translation to the clinic. It’s Frontier Fund is designed to assist BioTech companies to take their products to the market by overcoming financial barriers.
Snoretox wishes to thank RMIT University for it’s important assistance in winning this grant.
Snoretox also wishes to thank it’s collaborative partners: Venture Technology Group, Treidlia BioVet, Accelagen Consultants, Schafer Veterinary Consultants, and Mills Oakley Law Firm.
